Study Finds HA Injections Useful for Plantar Fasciopathy

Mary Ann Porucznik

Results of a multicenter, prospective, randomized, double-blind, placebo-controlled trial presented during the 2013 annual meeting of the American Orthopaedic Foot & Ankle Society (AOFAS) indicate that the use of high–molecular-weight hyaluronic acid (HA) injections may be effective in reducing pain and improving function in patients with plantar fasciopathy (PF).

According to presenter Tsukasa Kumai, MD, PhD, of Nara, Japan, PF is the most common cause of plantar heel pain. The diagnosis is fairly straightforward, based on a patient’s complaint of pain and tenderness on the medial plantar aspect of the calcaneus, and several conservative treatment options are available, including the following:

This content is only available to members of the AAOS.

Please log in using the link at the top right corner of this page to access your exclusive AAOS member content.

Not a member? Become a member!